Immucell News and Activities

Immucell is a company listed under the stock ticker ICCC (US).

View the org chart displaying its 19 main executives

Most searched biographies at Immucell

• Olivier Te Boekhorst, Chief Executive Officer and President
• Kathy Turner, Director
• David Tomsche, Chairman of the Board

Popular executive movements at Immucell

• Gilles Guillemette has joined the company as Director  (posted on April 14 2026).
• Anthony Dimarco has joined the company as Independent Director  (posted on April 14 2026).
• Kathy Turner will join the company as Director on Apr. 1, 2026  (posted on March 19 2026).

Click here to view some more movements at Immucell

Create your alert
to follow the executive moves at Immucell.

Immucell has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
• NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).
• Rallybio and Avenzo Therapeutics have announced they will merge  (posted on June 1 2026)..

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by Immucell

• 2025 Press Releases – Immucell | First DefenseToggle Menu
• 2024 Press Releases
• 2023 Press Releases
• 2022 Press Releases
• 2019 Press Releases – Immucell
• 2018 Press Release – Immucell
• 2015 Press Releases – Immucell
• 2014 Press Releases – Immucell
• 2016 Press Releases – Immucell
• 2017 Press Releases – Immucell
• View more press releases Close

Social media about Immucell

• Immucell on Wikipedia, Google News & Yahoo Finance
• Immucell on LinkedIn, X (Twitter) & YouTube